Glucocorticoids and COVID-19

Coronavirus Disease 19 (COVID-19) is associated with high morbidity and mortality rates globally, representing the greatest health and economic challenge today. Several drugs are currently approved for the treatment of COVID-19. Among these, glucocorticoids (GCs) have received particular attention d...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruscoli, Stefano, Puzzovio, Pier Giorgio, Zaimi, Maria, Tiligada, Katerina, Levi-Schaffer, Francesca, Riccardi, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556882/
https://www.ncbi.nlm.nih.gov/pubmed/36243331
http://dx.doi.org/10.1016/j.phrs.2022.106511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556882/
https://www.ncbi.nlm.nih.gov/pubmed/36243331
http://dx.doi.org/10.1016/j.phrs.2022.106511

Ejemplares similares